Quarterly history
AUM ($B)fundS&P 500(gap = α)/ Flow in/out
Behavior signals (lifetime)
Dip response
-1.32%
trims when stocks drop
when a holding falls −10%+
Middle response
-11.87%
baseline attrition
Rally response
-3.99%
trims into rallies
when a holding rises +10%+
Top positions · 1
| Ticker | $ value | % port | YoY | Hold time |
|---|---|---|---|---|
| AURAAura Biosciences, Inc. | $46M | 100.0% | +14.2% | 4.5 yr |
Portfolio composition (YoY)
Industry mix
Biotechnology100.0%+74.0pp$46M
Country
US100.0%+0.0pp
Top 5: 100.0% · Top 10: 100.0% · Top 25: 100.0%
Winners
| Ticker | Prev $ | PnL | YoY % |
|---|---|---|---|
| AURA | $41M | +0.01B | 14.2% |
Losers
| Ticker | Prev $ | PnL | YoY % |
|---|
Top buys this quarter · 0
No buys this quarter
Top sells this quarter · 1
| MAZE Maze Therapeutics, Inc.exit | −$14M |
Quarterly history (TTM returns)
| Period | AUM | # Pos | Return (1yr) | SPY (1yr) | Alpha (1yr) | Flow |
|---|---|---|---|---|---|---|
| 2026-03-31 | $46M | 1 | +53.96% | +17.59% | +36.37% | -0.02B |
| 2025-12-31 | $58M | 2 | +15.87% | +17.72% | -1.85% | -0.07B |
| 2025-09-30 | $107M | 3 | +1.17% | +17.52% | -16.35% | -0.15B |
| 2025-06-30 | $223M | 4 | -14.60% | +14.94% | -29.54% | -0.13B |
| 2025-03-31 | $347M | 4 | -15.24% | +8.30% | -23.54% | -1.44B |
| 2024-12-31 | $2.15B | 5 | +16.22% | +24.89% | -8.67% | -0.01B |
| 2024-09-30 | $2.09B | 7 | +28.39% | +36.04% | -7.65% | -10.70B |
| 2024-06-30 | $13.14B | 23 | +21.37% | +24.49% | -3.12% | +2.18B |
| 2024-03-31 | $10.77B | 23 | +34.32% | +29.62% | +4.70% | -0.27B |
| 2023-12-31 | $9.72B | 19 | +44.15% | +26.18% | +17.98% | +0.21B |
| 2023-09-30 | $8.34B | 19 | +26.18% | +21.57% | +4.61% | +0.41B |
| 2023-06-30 | $8.61B | 19 | +32.90% | +19.42% | +13.47% | +0.31B |
| 2023-03-31 | $7.36B | 17 | -12.73% | -7.82% | -4.91% | +0.98B |
| 2022-12-31 | $5.24B | 17 | -0.19% | +7.56% | -7.75% | +0.02B |
| 2022-09-30 | $5.23B | 26 | -3.05% | -4.93% | +1.88% | +0.95B |
| 2022-06-30 | $4.41B | 20 | -26.02% | -16.11% | -9.91% | -1.75B |